Consequently, we and others previously demonstrated that targeting Stat3 by upstream signaling inhibitors of the Stat3 pathway decreases glioma cell proliferation and migration in vitro and prolongs overall survival of tumor-bearing mice in vivo [19,20,21,22,23,24]. The gene discussed is STAT3; the disease is central nervous system cancer.